| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| gsk-677954 | peroxisome proliferator-activated receptor alpha | NA | Successful target | TTD | Non-alcoholic Fatty Liver Disease[MeSHID:D065626] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | discontinued in phase 2 | unknown |
| gsk-677954 | peroxisome proliferator-activated receptor delta | NA | Clinical trial target | TTD | Non-alcoholic Fatty Liver Disease[MeSHID:D065626] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | discontinued in phase 2 | unknown |
| gsk-677954 | peroxisome proliferator-activated receptor gamma | NA | Successful target | TTD | Non-alcoholic Fatty Liver Disease[MeSHID:D065626] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | discontinued in phase 2 | unknown |
| click here to return to the previous page | ||||||||